Literature DB >> 10064074

The resistance against Listeria monocytogenes and the formation of germinal centers depend on a functional death domain of the 55 kDa tumor necrosis factor receptor.

T Plitz1, U Huffstadt, R Endres, E Schaller, T W Mak, H Wagner, K Pfeffer.   

Abstract

The biological functions mediated by the death domain of the 55-kDa tumor necrosis factor receptor (TNFRp55) in vivo are still elusive. TNFRp55 mutants lacking a functional death domain were expressed in TNFRp55-/- and in TNFRp55+/- mice as transgenes under control of the H-2Kb promoter. Analysis of these animals revealed that signals originating from the TNFRp55 death domain are indispensable for the protection against Listeria monocytogenes, the expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in the spleen and the development of splenic germinal centers. Furthermore, the transgenic coexpression of the TNFRp55 mutants in TNFRp55+/- mice exerts a dominant negative effect on the signaling of the endogenous receptor chains in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10064074     DOI: 10.1002/(SICI)1521-4141(199902)29:02<581::AID-IMMU581>3.0.CO;2-A

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

1.  Intact lysosome transport and phagosome function despite kinectin deficiency.

Authors:  T Plitz; K Pfeffer
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

2.  Adaptive immunity against Listeria monocytogenes in the absence of type I tumor necrosis factor receptor p55.

Authors:  D W White; V P Badovinac; X Fan; J T Harty
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

3.  The TNFSF Members APRIL and BAFF and Their Receptors TACI, BCMA, and BAFFR in Oncology, With a Special Focus in Breast Cancer.

Authors:  Marilena Kampa; George Notas; Efstathios N Stathopoulos; Andreas Tsapis; Elias Castanas
Journal:  Front Oncol       Date:  2020-06-16       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.